ViroGates
Business Services · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Banevænget 13, Birkerod, Capital Region,...Phone Number
+45 21131336Website
www.virogates.comRevenue
<$5 MillionIndustry
About ViroGates
Is ViroGates your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ViroGates is spiking on competitors!
Earning: See what the market has to say on ViroGates recently announced quarterly report
Click to see if ViroGates had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ViroGates
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ViroGates, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ViroGates has new funding data
Check if ViroGates has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when ViroGates launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ViroGates
Compare insights from companies similar to ViroGates, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ViroGates
Company Profile Activity
Activity Insights
ViroGates is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ViroGates is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ViroGates.
ViroGates Tech Stack
A closer look at the technologies used by ViroGates
ViroGates News & Media
Västra Hamnen: ViroGates - Steadily growing customer base
Västra Hamnen Corporate Finance has published a research update on ViroGates following its Quarterly Report for Q2 2020. The numbers were in line with our expectations, and we look positively on the newly added clinical routine customers, writes Västra Hamnen. • Increasing attention on efficient triaging due to COVID-19 pandemic • Currently ten clinical routine customers • We keep our valuation interval unchanged at DKK 68.00 – 100.50 per share ViroGates’ report for Q2 2020 cViroGates Releases Third Quarter 2019 Results
Company announcement no. 13-2019 ViroGates announces clinical implementation of suPARnostic® TurbiLatex at University Hospital of Montpellier France
Company announcement no. 12-2019
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ViroGates
ViroGates specializes in advancing health through its innovative biomarker, suPAR, which is utilized in longevity, hospitals, and research. Their product line includes suPARnostic TurbiLatex, Quick Triage, and ELISA, aimed at improving health outcomes and clinical decision-making. The company targets healthcare and research professionals, providing... Read More